• Citer

Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?

par Hanquet, Germaine;Perrocheau, Anne;Kissling, Esther;Bruhl, Daniel Levy;Tarragó, David;Stuart, James;Stefanoff, Pawel;Heuberger, Sigrid;Kriz, Paula;Vergison, Anne ;de Greeff, Sabine C;Amato-Gauci, Andrew;Celentano, Lucia Pastore;ECDC Country Experts for Pneumococcal Disease,
Référence Vaccine, 28, 23, page (3920-3928)
Publication Publié, 2010-05

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Résumé :

In this era of new pneumococcal conjugate vaccines (PCV), we described and compared surveillance of invasive pneumococcal disease (IPD) and PCV policies in 30 European countries to provide guidance for Europe-wide surveillance. We confirmed the heterogeneity of surveillance systems and case definitions across countries but identified elements common to all countries, such as the availability of serotyping and the surveillance of pneumococcal meningitis. PCV impact was monitored in 11/15 countries using it. We propose steps for the monitoring of incidence rates and serotype distribution at EU level, to assess the need to introduce PCV and monitor its impact once introduced.